Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon alpha 2b for basal cell carcinoma
IRCT2017093017756N30Phase 2Completed
- Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Start
- Mar 2017
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa-2b in basal cell carcinoma (BCC), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Started Mar 2017; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on IRCT2017093017756N30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017093017756N30.